Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS
Ingrid Walter(University of Veterinary Medicine Vienna), Ralf Steinborn(University of Vienna)
Cited by 14
Related Papers
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363